Profile image of Professor Nigel Irwin

Professor Nigel Irwin

Professor

Profile image of Professor Nigel Irwin

Research

Biomedical Sciences Research

Location

Room W1083 Cromore Road Coleraine Co. Londonderry BT52 1SA

Telephone

Overview

Dr Nigel Irwin holds a BSc Hons in Biomedical Sciences from Ulster University (2001) and a PhD in Experimental Therapeutics for Diabetes also from Ulster (2004). He also has a Diploma in Industrial Studies (2001) and is a Fellow of HEA (2008).

Nigel began his research career in diabetes during his time as a Research Assistant in Diabetes/Electrophysiology, at University of Nevada, Reno (2000-2001). This was followed by appointment at Ulster as a Research Associate (2004-2007) and a Research Fellow (2007-2009) in Diabetes. He then became a Lecturer in Pharmacology (2009-2014) and Senior Lecturer in 2014.

He has almost 20 years experience in diabetes research with specific expertise in exploitation of gut-derived peptides for the treatment of diabetes and related disorders. His recent research has been integral in deciphering the link between diabetes and increased bone fracture risk.

Nigel is holder of several families of patents, is the recipient of research awards, and a member of healthcare science advisory boards as well as engaging in consultant activity.

He is also a member of several professional societies/committees and holds editorial roles for various respected Journals.

Research Interests

  • New perspectives on gut peptides for the treatment of diabetes
  • Pharmacological characterisation of current and novel antidiabetic drugs
  • Diabetes and bone quality

Teaching Interests

  • Pharmacology
  • Immunology
  • Drug Discovery
  • Pharmaceutical Biotechnology

Administrative Roles

  • Module Co-ordinator
  • Senior Radiation Protection supervisor
  • School of Pharmacy and Pharmaceutical science undergraduate attendance monitor
  • Various Editor-in-Chief and journal editorial roles

Research Opportunities

Research Opportunities with Professor Nigel Irwin
Title Closing Date  
Utility of combined GLP-1 and neurotensin receptor signalling, and/or related hybrid peptides, for type 2 diabetes therapy Self-funded PhD Opportunity Tuesday 1 September 2020 View Details
Diabetes N/A View Details